UPC Analytics
ENDE
Overview · Filed:

UPC_APP_24524/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsCase Management OrdersMunich LDApplication Rop 333
  • 2025-06-27Procedural onlyproceduralApplication Rop 333

    Procedural order from the Munich Local Division (UPC_CFI_148/2024 and UPC_CFI_503/2024) on Zentiva's application under R. 333 RoP for panel review of the judge-rapporteur's case management order of 8 May 2025 in Sanofi's infringement action concerning EP 2 493 466. The full panel reviewed how preliminary objections should be handled and the timetable for subsequent proceedings.